News (Life Sciences & Healthcare)

04-Sep-2008  |  Life Sciences & Healthcare

Taylor Wessing advises Asterand plc on licence agreement with Allergan Inc

Taylor Wessing's Life Sciences & Healthcare Group has advised new client Asterand plc, a leading global provider of human ... more

03-Sep-2008  |  Life Sciences & Healthcare

Taylor Wessing advises Biota on RSV collaboration and licence agreement

Taylor Wessing's Life Sciences & Healthcare Group has advised new client Biota Holdings Limited, a leading anti-infective ... more

08-Jul-2008  |  Corporate, Life Sciences & Healthcare, Tax, Technology

Taylor Wessing advises NovaThera on £30m merger with MedCell

Taylor Wessing LLP has advised NovaThera on their merger with MedCell, to create a new UK company specialising in musculoskeletal ... more

02-May-2008  |  China, Intellectual Property, Life Sciences & Healthcare, Media & Entertainment, Technology, The Middle East

Comprehensive ranking of the world's IP jurisdictions

For a detailed breakdown of the IP Index including rankings, country analysis and commentary on the findings, rationale and ... more

10-Apr-2008  |  Intellectual Property, Life Sciences & Healthcare

Taylor Wessing scoops MIP award for European Life Sciences IP Firm of the Year

Taylor Wessing was voted European Life Sciences IP Firm of the Year at the third annual Managing Intellectual Property Global ... more

02-Jan-2008  |  Corporate, Intellectual Property, Life Sciences & Healthcare

Taylor Wessing advises Fovea Pharmaceuticals on its €30m second financing round

Fovea Pharmaceuticals SA, a biomedical and technological company specialising in the development of innovative drug therapy for ... more

05-Dec-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises Vivacta on £6 million Series B fundraising

Taylor Wessing in London has acted for Vivacta Limited on a £6 million Series B fundraising round. European Venture Capital firms ... more

11-Oct-2007  |  Intellectual Property, Life Sciences & Healthcare

Taylor Wessing is the exclusive European legal sponsor of the 15th Annual BioPartnering Europe Conference

Taylor Wessing is the exclusive European legal sponsor of the 15th Annual BioPartnering Europe (BPE) Conference, on 7-9 October ... more

30-Mar-2007  |  Corporate, Intellectual Property, Life Sciences & Healthcare

Taylor Wessing advises Oxford BioMedica on global licensing agreement with Sanofi-aventis

Taylor Wessing advised Oxford BioMedica (LSE: OXB) and Sanofi-Aventis (EURONEXT: SAN; NYSE: SNY) on an exclusive global licensing ... more

26-Mar-2007  |  Corporate, Life Sciences & Healthcare

Taylor Wessing advises on €9 million subscription and placing for AIM-listed company, Arthro Kinetics plc

Taylor Wessing advised on €9 million subscription and placing for Arthro Kinetics plc, an orthopaedics company dedicated to ... more

04-Jan-2007  |  Corporate, Finance, Life Sciences & Healthcare

Taylor Wessing advises Synergy Healthcare plc on its £181 million takeover offer for Isotron plc

Taylor Wessing is advising Synergy Healthcare plc, the AIM-quoted healthcare services provider, on its recommended, increased ... more

06-Oct-2006  |  Intellectual Property, Life Sciences & Healthcare, Real Estate

Taylor Wessing represents the "Men in Scarlet" on Royal Hospital Chelsea's new Infirmary

Taylor Wessing advised the Royal Hospital Chelsea on the construction contract to rebuild its new infirmary; the first stage of a ... more

10-Apr-2006  |  Intellectual Property, Life Sciences & Healthcare

Taylor Wessing advises Innate Pharma on major partnership with Novo Nordisk

Taylor Wessing advised Innate Pharma, the Marseille-based biotechnology company, on a major partnership with Novo Nordisk, the ... more

08-Mar-2006  |  Corporate, Employment & Pensions, Intellectual Property, Life Sciences & Healthcare

Taylor Wessing advises PanOpSys Limited on a $5.25 million Series A funding with Quester

The venture capital group at European law firm, Taylor Wessing, has advised PanOpSys Limited, a medical diagnostics company ... more

25-Jul-2005  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Tax

Taylor Wessing advises Xention Discovery Ltd on its £11m venture capital funding

Taylor Wessing's Cambridge office has advised Xention Discovery Ltd, an emerging pharmaceutical company specialising in ion ... more

28-Jun-2005  |  Corporate, Employment & Pensions, Life Sciences & Healthcare, Technology

Taylor Wessing advises on £4m spinal investment

Taylor Wessing advised FNI Venture Capital on its investment of £4m in a second institutional financing round for Ranier ... more

27-Jun-2005  |  Corporate, Life Sciences & Healthcare, Technology

Taylor Wessing advises on Europe's largest venture capital fund raising this year

Taylor Wessing has acted for MPM Capital, a global investment firm focused solely on investing in life sciences in its role as ... more

25-Apr-2005  |  Employment & Pensions, Intellectual Property, Leisure, Life Sciences & Healthcare, Litigation & Dispute Resolution, Real Estate

Five new partners at Taylor Wessing

Taylor Wessing is pleased to announce the appointment of five new partners in the UK office with effect from 1 May 2005. This ... more

03-Mar-2005  |  Corporate, Life Sciences & Healthcare, Technology

Taylor Wessing advises Sphere Medical Holdings

Taylor Wessing's Cambridge office has advised Sphere Medical Holding Limited on a £4 million series of technology funding ... more